Drug Topics

MARCH 18, 2024

AstraZeneca is the second pharmaceutical company to cap out-of-pocket costs for eligible patients.

Pharmaceutical Companies 144

Pharmaceutical Companies Pharmaceutical Companies 144

STAT

MARCH 18, 2024

The biggest enticement that large pharmacy benefit managers offer to the employers that hire them is drug rebates — a steady stream of money sent back to their clients, a tangible symbol of the discounts that PBMs are able to wrangle out of pharmaceutical companies. PBMs, the middlemen of drug pricing negotiations, also claim portions of those lucrative rebates for themselves.

Documentation 144

Documentation Pharmaceutical Companies Pharmaceutical Companies Insurance 144

Pharmacy Times

MARCH 18, 2024

The decision to vote in favor of idecabtagene vicleucel comes after positive phase 3 trial results demonstrating its efficacy compared with standard regimens.

FDA 142

FDA 142

STAT

MARCH 18, 2024

The Food and Drug Administration on Monday approved a gene therapy for metachromatic leukodystrophy, a devastating genetic disorder that eats away at affected children’s neurons. The medicine, marketed as Lenmeldy, is the first treatment for MLD, which is otherwise fatal. Lenmeldy has to be given before symptoms appear or, in some cases, after the first signs of disease, so it won’t be helpful for many patients living with MLD today.

FDA 124

FDA 124

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Pharmacy Times

MARCH 18, 2024

High bacterial load in cerebrospinal fluid was associated with unfavorable outcomes and death for adults with pneumococcal meningitis.

138

138

Fierce Pharma

MARCH 18, 2024

Two months after GSK sold a significant chunk of its stake in Haleon, Pfizer is | Two months after GSK sold a significant chunk of its stake in Haleon, Pfizer is prepared to do the same with a larger selloff, according to the consumer healthcare company. Pfizer is set to reduce its stake in Haleon from 32% to 24% by selling 630 million shares in a public offering.

124

124

Fierce Healthcare

MARCH 18, 2024

The NCAA basketball tournament gets underway today, and the Fierce Healthcare team is gearing up yet again for our annual #FierceMadness competition. | The NCAA basketball tournament gets underway today, and the Fierce Healthcare team is gearing up yet again for our annual #FierceMadness competition.

123

123

Pharmacy Times

MARCH 18, 2024

The FDA-approved topical and oral agent is currently indicated for adult patients with patterned alopecia.

Chemotherapy 132

Chemotherapy FDA 132

Pharmaceutical Technology

MARCH 18, 2024

Akums Drugs and Pharmaceuticals has introduced Hydroxyurea oral suspension, a room temperature-stable drug for treating sickle cell disease.

122

122

Pharmacy Times

MARCH 18, 2024

The authors note that understanding the DNA methylation profile in leukemia can help predict whether or not a patient will respond to treatment.

122

122

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fierce Pharma

MARCH 18, 2024

Kyowa Kirin’s bet on Orchard Therapeutics has paid off, furnishing the Japanese drugmaker with a newly approved gene therapy in the U.S. | The FDA on Monday gave a thumbs up to Lenmeldy as the first gene therapy in the U.S. for kids with certain types of metachromatic leukodystrophy (MLD).

FDA 122

FDA 122

pharmaphorum

MARCH 18, 2024

Discover the top 7 challenges faced by pharmaceutical and life sciences companies in achieving patient-centricity and engaging healthcare professionals (HCPs). Explore strategies to overcome these obstacles for successful outreach efforts.

119

119

Pharmacy Times

MARCH 18, 2024

Michael Singel, PharmD, discusses the role of pharmacists in the operationalization of bispecifics to treat multiple myeloma, including the creation of treatment plans and standard of care order sets.

114

114

pharmaphorum

MARCH 18, 2024

FDA advisors have said that two BCMA-targeted CAR-T therapies can be used earlier in the treatment pathway for multiple myeloma, setting up FDA approvals for use in a broader patient population.

FDA 115

FDA 115

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Healthcare

MARCH 18, 2024

High-risk Clover Health members can now take advantage of Quartet Health's behavioral health offerings to help individuals suffering from serious mental illness. | Quartet Health is partnering with Clover Health to help the insurtech's most complex patients suffering from serious mental illness.

109

109

pharmaphorum

MARCH 18, 2024

Agreement has been reached in the EU on a European Health Data Space (EHDS), which will make it easier to exchange and access electronic health data.

111

111

Fierce Pharma

MARCH 18, 2024

As bluebird bio works to make the most of three gene therapy launches, cash-flow concerns have been looming over the drugmaker. | The funding should extend bluebird bio's cash runway through the first quarter of 2026 as it advances three gene therapy launches. Previously, the company expected its cash to run out by this year's second quarter.

106

106

pharmaphorum

MARCH 18, 2024

AI software designed to tackle missed appointments and reduce waiting lists will see its use by NHS England ramp up after a successful pilot deployment.

110

110

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

European Pharmaceutical Review

MARCH 18, 2024

A study has determined that intermittent low-intensity far-UVC light can inhibit mould growth below the threshold limit value of 23 mJ/cm 2. At 222nm, far-UVC light was shown to prevent development of common mould-producing fungi , specifically Penicillium candidum. The on-off duty cycle pattern of the far-UVC light used in the study is “consistent with its use in real-world settings”, the corresponding paper stated.

105

105

pharmaphorum

MARCH 18, 2024

GSK's PD-1 inhibitor Jemperli improves overall survival when used first-line in an all-comer endometrial cancer trial

106

106

Pharmacy Times

MARCH 18, 2024

Laura Brown, MS, RDN, LDN, discusses the importance of National Nutrition Month, collaborating with pharmacists, promoting sustainable eating habits, and overcoming common nutrition misconceptions

105

105

Pharmaceutical Commerce

MARCH 18, 2024

In this Pharmaceutical Commerce video interview, Joerg Tritschler, a partner in Simon-Kucher’s life sciences division, discusses the positive signs from rising activity levels in biopharma M&A— and what the momentum may mean for industry dealmaking and partnership efforts in the months ahead.

105

105

Fierce Healthcare

MARCH 18, 2024

President Joe Biden will sign an executive order Tuesday instructing federal agencies to ramp up research into women’s health, with cross-department priorities ranging from women’s midlife health c | The White House is greenlighting new federal research into post-menopause healthcare conditions, Medicare coverage, data collection, provider resources and AI-supported women's health research.

104

104

Fierce Pharma

MARCH 18, 2024

After a quick FDA approval in a subset of endometrial cancer, GSK is back with more data for two Jemperli regimens in hopes of reaching a broader patient population. | After a quick FDA approval in a subset of endometrial cancer, GSK is back with more data for two Jemperli regimens—including one with a PARP drug—in hopes of reaching a broader patient population.

FDA 104

FDA 104

STAT

MARCH 18, 2024

Investors are starting to back startups that offer privacy and security services to bolster health AI products already on the market while they wait for crucial safety and privacy regulations to take shape. Though health leaders are racing to deploy generative AI products that can automatically transcribe doctor-patient conversations during medical appointments or churn through massive repositories of scientific research, they’re still flummoxed about how to measure their quality.

Hospitals 103

Hospitals 103

pharmaphorum

MARCH 18, 2024

Bristol-Myers Squibb gets its $14bn takeover of Karuna Therapeutics over the finish line, taking control of schizophrenia candidate KarXT ahead of an FDA decision in September

FDA 101

FDA 101

Drug Topics

MARCH 18, 2024

A lack of diversity in clinical trials has hampered health care providers from understanding the nuances of diseases across specific patient populations.

98

98

pharmaphorum

MARCH 18, 2024

Orchard's gene therapy for MLD finally gets US approval Jonah.

98

98

Drug Topics

MARCH 18, 2024

This video was sponsored by Otsuka Pharmaceutical Development & Commercialization, Inc. in collaboration with Lundbeck LLC.

98

98

European Pharmaceutical Review

MARCH 18, 2024

A Phase III trial has shown that compared oral drug delivery, administering levodopa through an infusion pump led to nearly two hours of day (1.72) of additional time in which the medicine reduced symptoms in Parkinson’s patients. There were 381 Parkinson’s patients enrolled in the trial. Levodopa was delivered for 24 hours via a subcutaneous infusion pump, which was shown to be a safe method of drug delivery, the research found.

FDA 98

FDA 98

Drug Topics

MARCH 18, 2024

Hypertension remains a significant problem in areas of the rural South.

98

98

The Checkup by Singlecare

MARCH 18, 2024

Maybe it’s the coffee you drink every morning. Or the yogurt that got pushed to the back of the fridge. Or a forgotten bunch of now-wilting spinach. Everything in the refrigerator and kitchen cabinets has an expiration date, and the medicine cabinet is no exception. The law requires all medications to have printed expiration dates, so the clock is ticking once you break the safety seal on ibuprofen.

Hospitals 98

Hospitals FDA 98

pharmaphorum

MARCH 18, 2024

The PM Society’s 38th annual awards were held last week, on Friday 15th March, at the JW Marriott Grosvenor House London, at which over 900 industry professionals came together to celebrate the best in creative, impactful, and innovative communications in pharma and healthcare.

Communication 98

Communication 98